4170 (Taiwan) Insiders

4170 Stock  TWD 13.80  1.75  11.25%   
Recap of 4170's management performance can provide insight into the venture performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4170. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Symbol  4170
Name  4170
TypeStock
Country  
 Taiwan
Exchange  TWO

Information on 4170 Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

4170 Management Team Effectiveness

The company has return on total asset (ROA) of (8.59) % which means that it has lost $8.59 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (8.33) %, meaning that it generated substantial loss on money invested by shareholders. 4170's management efficiency ratios could be used to measure how well 4170 manages its routine affairs as well as how well it operates its assets and liabilities.
Some institutional investors establish a significant position in stocks such as 4170 in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of 4170, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

4170 Workforce Comparison

4170 is number one stock in number of employees category among its peers. The total workforce of Diagnostics & Research industry is presently estimated at about 270. 4170 holds roughly 10.0 in number of employees claiming about 4% of equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of (14.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (32.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $32.96.

4170 Benchmark Summation

String symbol = request.getParameter("s");

About 4170 Management Performance

The success or failure of an entity such as 4170 often depends on how effective the management is. 4170 management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 4170 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 4170 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vectorite Biomedical Inc. engages in the research and development of immune cell storage and treatment technology in Taiwan, China, and the United States. Vectorite Biomedical Inc. was founded in 2004 and is based in New Taipei City, Taiwan. VECTORITE BIOTECH operates under Diagnostics Research classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in 4170's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 4170. Check 4170's Beneish M Score to see the likelihood of 4170's management manipulating its earnings.

Additional Tools for 4170 Stock Analysis

When running 4170's price analysis, check to measure 4170's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4170 is operating at the current time. Most of 4170's value examination focuses on studying past and present price action to predict the probability of 4170's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4170's price. Additionally, you may evaluate how the addition of 4170 to your portfolios can decrease your overall portfolio volatility.